ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 145 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $155,499,000 | +60.2% | 8,244,896 | 0.0% | 5.20% | +89.5% |
| Q2 2019 | $97,042,000 | -13.8% | 8,244,896 | 0.0% | 2.75% | -16.6% |
| Q1 2019 | $112,543,000 | +68.8% | 8,244,896 | +26.7% | 3.29% | +22.8% |
| Q4 2018 | $66,684,000 | -38.4% | 6,505,766 | 0.0% | 2.68% | -19.5% |
| Q3 2018 | $108,321,000 | +5.4% | 6,505,766 | 0.0% | 3.33% | -4.6% |
| Q2 2018 | $102,791,000 | +24.4% | 6,505,766 | 0.0% | 3.49% | +9.5% |
| Q1 2018 | $82,623,000 | +10.9% | 6,505,766 | 0.0% | 3.19% | -1.5% |
| Q4 2017 | $74,491,000 | -6.1% | 6,505,766 | +0.4% | 3.24% | -17.3% |
| Q3 2017 | $79,340,000 | +211.6% | 6,476,766 | +191.2% | 3.91% | +152.5% |
| Q2 2017 | $25,463,000 | -35.9% | 2,223,811 | +16.4% | 1.55% | -39.9% |
| Q1 2017 | $39,726,000 | +107.5% | 1,909,886 | +107.5% | 2.58% | +56.2% |
| Q4 2016 | $19,147,000 | -16.8% | 920,550 | +31.0% | 1.65% | -9.9% |
| Q3 2016 | $23,022,000 | – | 702,539 | – | 1.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |